000 01135 a2200313 4500
005 20250516123916.0
264 0 _c20130619
008 201306s 0 0 eng d
022 _a1557-8593
024 7 _a10.1089/dia.2012.0294
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRodriguez, Henry
245 0 0 _aNew technologies and old challenges in type 1 diabetes.
_h[electronic resource]
260 _bDiabetes technology & therapeutics
_cDec 2012
300 _a1082-3 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aBiosensing Techniques
650 0 4 _aBlood Glucose
_xdrug effects
650 0 4 _aDiabetes Mellitus, Type 1
_xdrug therapy
650 0 4 _aDiabetic Ketoacidosis
_xmortality
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypoglycemic Agents
_xadministration & dosage
650 0 4 _aInsulin
_xadministration & dosage
650 0 4 _aInsulin Infusion Systems
_xadverse effects
650 0 4 _aMale
773 0 _tDiabetes technology & therapeutics
_gvol. 14
_gno. 12
_gp. 1082-3
856 4 0 _uhttps://doi.org/10.1089/dia.2012.0294
_zAvailable from publisher's website
999 _c22324021
_d22324021